Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Family Office of AmericaFOFA -18.18%19 Debt-to-EBITDA is 0.38 as of Mar. 2026. GuruFocus rates FOFA with a GF Score™ of 19/100. Among 467 Medical Devices & Instruments companies, Family Office of America ranks worse than 214132.55% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Family Office of America's Debt-to-EBITDA or its related term are showing as below:
FOFA'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -10.16 Med: -0.06 Max: 9.38
Current: -10.16
During the past 11 years, the highest Debt-to-EBITDA Ratio of Family Office of America was 9.38. The lowest was -10.16. And the median was -0.06.
FOFA's Debt-to-EBITDA is ranked worse than 100% of 467
companies
in the Medical Devices & Instruments industry
Industry Median: 1.57
vs FOFA: -10.16
Family Office of America (OTCPK:FOFA) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Family Office of America Debt-to-EBITDA Related Terms
Family Office of America Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FOFA vs PAVM, BDMD, TELA: Debt-to-EBITDA Comparison
For the Medical Devices subindustry, Family Office of America's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Family Office of America Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Family Office of America's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Family Office of America's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Family Office of America (FOFA) has a Debt-to-EBITDA of 0.38 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Family Office of America. According to the industry distribution chart, Family Office of America ranks #999999 out of 467 companies in the Medical Devices & Instruments industry.
Is Family Office of America's Debt-to-EBITDA too high?
Family Office of America's current Debt-to-EBITDA is 0.38. The Medical Devices & Instruments industry median Debt-to-EBITDA is 1.57. Family Office of America's value of 0.38 is 75.8% below this industry median. Based on the distribution chart, Family Office of America ranks #999999 out of 467 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Family Office of America has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Family Office of America's Debt-to-EBITDA compare to PAVM and BDMD?
According to the Medical Devices & Instruments industry distribution chart, Family Office of America ranks #999999 out of 467 companies for Debt-to-EBITDA. This places Family Office of America in the lower half of its industry. The industry median Debt-to-EBITDA is 1.57. Family Office of America's value of 0.38 is 75.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.57, based on 467 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Family Office of America's current Debt-to-EBITDA of 0.38 is 75.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Family Office of America. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Family Office of America's current Debt-to-EBITDA is 0.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Family Office of America stock overvalued right now?
Family Office of America (FOFA) has a current Debt-to-EBITDA of 0.38. The current Debt-to-EBITDA is 0.38 and 75.8% below the Medical Devices & Instruments industry median of 1.57. Family Office of America's overall GF Score™ is 19/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Family Office of America (FOFA), the current Debt-to-EBITDA is 0.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Family Office of America Inc is engaged in providing CPA services, tax planning and preparation, wealth management, asset management, estate planning, asset protection, insurance consulting, and investment banking.
19GF Score
Get the complete analysis for FOFA
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FOFA has been successfully added to your 
